BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11584151)

  • 1. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration.
    Lallemand F; Soubrié PH; De Witte PH
    Alcohol Clin Exp Res; 2001 Sep; 25(9):1317-23. PubMed ID: 11584151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic alcohol administration combined with repeated re-exposures and withdrawals.
    Lallemand F; Soubrié P; De Witte P
    Alcohol Alcohol; 2004; 39(6):486-92. PubMed ID: 15466898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers.
    Rodríguez de Fonseca F; Roberts AJ; Bilbao A; Koob GF; Navarro M
    Zhongguo Yao Li Xue Bao; 1999 Dec; 20(12):1109-14. PubMed ID: 11189201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SR147778, a CB1 cannabinoid receptor antagonist, suppresses ethanol preference in chronically alcoholized Wistar rats.
    Lallemand F; De Witte P
    Alcohol; 2006 Jul; 39(3):125-34. PubMed ID: 17127132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats.
    Cippitelli A; Bilbao A; Hansson AC; del Arco I; Sommer W; Heilig M; Massi M; Bermúdez-Silva FJ; Navarro M; Ciccocioppo R; de Fonseca FR;
    Eur J Neurosci; 2005 Apr; 21(8):2243-51. PubMed ID: 15869521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SR141716A on ethanol and sucrose self-administration.
    Freedland CS; Sharpe AL; Samson HH; Porrino LJ
    Alcohol Clin Exp Res; 2001 Feb; 25(2):277-82. PubMed ID: 11236843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats.
    Morales M; McGinnis MM; McCool BA
    Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):67-76. PubMed ID: 26515190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.
    Pavon FJ; Bilbao A; Hernández-Folgado L; Cippitelli A; Jagerovic N; Abellán G; Rodríguez-Franco MA; Serrano A; Macias M; Gómez R; Navarro M; Goya P; Rodríguez de Fonseca F
    Neuropharmacology; 2006 Aug; 51(2):358-66. PubMed ID: 16750544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol induces higher BEC in CB1 cannabinoid receptor knockout mice while decreasing ethanol preference.
    Lallemand F; de Witte P
    Alcohol Alcohol; 2005; 40(1):54-62. PubMed ID: 15550449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice.
    Wang L; Liu J; Harvey-White J; Zimmer A; Kunos G
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1393-8. PubMed ID: 12538878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.
    Arnone M; Maruani J; Chaperon F; Thiébot MH; Poncelet M; Soubrié P; Le Fur G
    Psychopharmacology (Berl); 1997 Jul; 132(1):104-6. PubMed ID: 9272766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological manipulation of CB1 receptor function alters development of tolerance to alcohol.
    Nowak KL; Vinod KY; Hungund BL
    Alcohol Alcohol; 2006; 41(1):24-32. PubMed ID: 16216824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressing effect of the cannabinoid CB1 receptor antagonist, SR147778, on alcohol intake and motivational properties of alcohol in alcohol-preferring sP rats.
    Gessa GL; Serra S; Vacca G; Carai MA; Colombo G
    Alcohol Alcohol; 2005; 40(1):46-53. PubMed ID: 15582988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cannabinoid CB1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat.
    Chapman V
    Br J Pharmacol; 1999 Aug; 127(8):1765-7. PubMed ID: 10482905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors.
    Thanos PK; Dimitrakakis ES; Rice O; Gifford A; Volkow ND
    Behav Brain Res; 2005 Nov; 164(2):206-13. PubMed ID: 16140402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716.
    Colombo G; Agabio R; Fà M; Guano L; Lobina C; Loche A; Reali R; Gessa GL
    Alcohol Alcohol; 1998; 33(2):126-30. PubMed ID: 9566474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of alcohol preference by NMDA antagonists in male rats.
    Lamblin F; Deuceuninck D; De Witte P
    Alcohol Alcohol; 1993 Nov; 28(6):639-47. PubMed ID: 7908524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microstructural analysis of rat ethanol and water drinking patterns using a modified operant self-administration model.
    Robinson SL; McCool BA
    Physiol Behav; 2015 Oct; 149():119-30. PubMed ID: 26037631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments.
    Rubino T; Viganò D; Zagato E; Sala M; Parolaro D
    Synapse; 2000 Jan; 35(1):8-14. PubMed ID: 10579803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl) -4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats.
    Solinas M; Panlilio LV; Antoniou K; Pappas LA; Goldberg SR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):93-102. PubMed ID: 12660305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.